Diagnosis & Disease Information

Researchers sought to develop a prognostic model for outcomes in pediatric patients with classical Hodgkin lymphoma based on gene expression data.

Researchers sought to determine whether brentuximab vedotin with bendamustine would be effective in pediatric patients with relapsed or refractory Hodgkin lymphoma.

Researchers sought to determine whether using LF-radiotherapy would reduce excess long-term morbidity among patients with stage I-IIa classical Hodgkin lymphoma.

Researchers sought to determine if high total metabolic tumor volume by baseline PET1 reading is linked with outcomes for patients with HIV-associated Hodgkin lymphoma.

Researchers sought to determine whether pediatric patients with intermediate- or advanced-stage classical Hodgkin lymphoma could safely omit radiotherapy.

Researchers sought to determine whether radiomic features of baseline 18F-fluorodeoxyglucose PET would help predict survival outcomes in Hodgkin lymphoma.

Researchers sought to determine whether combining brentuximab vedotin with nivolumab would have positive PFS in patients with cHL.